Fundraising Fox
NanoStics
Edmonton, CA · 2 known investors
Find your way into NanoStics
Sign up to see every warm intro you have to NanoStics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NanoStics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nanostics is a precision health company developing non-invasive diagnostic tests and medical devices that use machine learning to detect and assess aggressive cancers such as prostate cancer, aiming to improve diagnosis and healthcare decisions. It serves clinicians and patients in the cancer diagnostics field.
Founders & leadership
JD
John D. LewisFounder, Board Chair & CEOJohn D. Lewis founded Nanostics, a precision health company developing non-invasive diagnostic tests using machine learning to detect aggressive cancers. His research background spans nanotechnology and imaging technologies applied to chronic diseases including cancer metastasis.
EH
Eric HyndmanMedical Officer
CV
Catalina VasquezChief Operating OfficerCatalina Vasquez is Chief Operating Officer of NanoStics, a precision health company developing non-invasive diagnostic tests for aggressive cancers using machine learning.
DP
Desmond PinkChief Scientific OfficerDesmond Pink has spent over a decade in biotechnology development and translational science, with expertise spanning amino acid biochemistry, tumor biology, intravital imaging, and targeted lipid nanoparticle delivery. He is Co-Founder and Chief Scientific Officer of Nanostics, a University of Alberta spin-off developing liquid biopsy diagnostics that combine clinical biomarkers and machine learning for cancer risk assessment.
CC
Colin CorosChief Commercialization OfficerColin Coros is Chief Commercialization Officer of NanoStics, a precision health company developing non-invasive diagnostic tests for aggressive cancers. He has background in biotechnology, finance, and business development.
Investors · 2
Related companies · 7
NanodiagnosticsNanoDx develops point-of-care diagnostic devices using nanowire biosensor technology to deliver rapid test results at patient locations, targeting unmet clinical needs globally.
NosticsNostics develops a portable optical biosensor that measures real-time spectral signals from pathogens in patient samples, using its Spectral Foundation Model to identify infections at the point of care in under 10 minutes. The platform targets healthcare providers seeking rapid, lab-comparable infection diagnostics for decentralized settings and to address antimicrobial resistance.
NanobiotixNanobiotix develops physics-based nanotherapeutics for cancer treatment, applying nanotechnology to expand therapeutic options for oncology patients. The company builds on French scientific research and targets patients worldwide through disruptive treatment approaches.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
NOWDiagnostics (NOWDx)NOWDiagnostics develops rapid, point-of-care and consumer diagnostic tests. The company operates in the medical diagnostics and MedTech industry.
RadioneticsRadionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands. The company is headquartered in San Diego, California, and focuses on theranostic applications in oncology.
Fortis Life SciencesFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
Companies working in the same space as NanoStics.
Frequently asked questions
- What does NanoStics do?
- Nanostics is a precision health company developing non-invasive diagnostic tests and medical devices that use machine learning to detect and assess aggressive cancers such as prostate cancer, aiming to improve diagnosis and healthcare decisions. It serves clinicians and patients in the cancer diagnostics field.
- Who founded NanoStics?
- NanoStics was founded by John D. Lewis, Robert Paproski.
- Who are NanoStics's investors?
- NanoStics's investors include ScaleGood Fund LP (powered by TELUS), Startup TNT.
- Where is NanoStics headquartered?
- NanoStics is headquartered in Edmonton, CA.